Precision Medicine for Obesity Treatment

Area of Science:

• Endocrinology and Metabolism
• Genetics and Genomics
• Personalized Medicine

Background:

• Obesity is a complex chronic disease with rising prevalence, leading to significant morbidity, mortality, and healthcare costs.
• Current lifestyle interventions often yield insufficient weight loss, necessitating pharmacotherapy or surgical options.
• Existing obesity treatments show considerable inter-individual response variability, highlighting limitations of the "one-size-fits-all" approach.

Purpose of the Study:

• To explore the potential of precision medicine in optimizing obesity management.
• To investigate how multi-omics technologies can enhance patient stratification and identify novel therapeutic targets.
• To shift obesity care towards a more individualized and mechanism-based strategy.

Main Methods:

• Review of current obesity management strategies and their limitations.
• Exploration of advancements in multi-omics technologies (genomics, proteomics, metabolomics, microbiome profiling).
• Analysis of how these technologies can inform personalized treatment selection.

Main Results:

• Precision medicine, integrating genetic, physiological, and behavioral data, can address treatment variability.
• Multi-omics technologies provide novel opportunities for patient stratification and discovery of therapeutic targets.
• Individualized approaches promise improved weight-loss outcomes and comorbidity management.

Conclusions:

• A precision medicine framework is crucial for advancing obesity care beyond current limitations.
• Leveraging multi-omics data can lead to more effective and personalized obesity treatments.
• Future research should focus on integrating these technologies for mechanism-based, individualized obesity management.